Next Article in Journal
Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States
Previous Article in Journal
Developments in Stereotactic Body Radiotherapy
Article Menu

Export Article

Open AccessArticle
Cancers 2018, 10(12), 498; https://doi.org/10.3390/cancers10120498

IL-12 Gene Electrotransfer Triggers a Change in Immune Response within Mouse Tumors

1
Frank Reidy Research Center for Bioelectrics, Old Dominion Unviersity, Norfolk, VA 23508, USA
2
School of Medical Diagnostics and Translational Science, Old Dominion University, Norfolk, VA 23508, USA
*
Author to whom correspondence should be addressed.
Received: 25 October 2018 / Revised: 5 December 2018 / Accepted: 5 December 2018 / Published: 8 December 2018
Full-Text   |   PDF [7030 KB, uploaded 8 December 2018]   |  

Abstract

Metastatic melanoma is an aggressive skin cancer with a relatively low survival rate. Immune-based therapies have shown promise in the treatment of melanoma, but overall complete response rates are still low. Previous studies have demonstrated the potential of plasmid IL-12 (pIL-12) delivered by gene electrotransfer (GET) to be an effective immunotherapy for melanoma. However, events occurring in the tumor microenvironment following delivery have not been delineated. Therefore, utilizing a B16F10 mouse melanoma model, we evaluated changes in the tumor microenvironment following delivery of pIL-12 using different GET parameters or injection of plasmid alone. The results revealed a unique immune cell composition after intratumoral injection of pIL-12 GET. The number of immune memory cells was markedly increased in pIL-12 GET melanoma groups compared to control group. This was validated using flow cytometry to analyze peripheral blood mononuclear cells as well as delineating immune cell content using immunohistochemistry. Significant differences in multiple cell types were observed, including CD8+ T cells, regulatory T cells and myeloid cells, which were induced to mount a CD8+PD1 T cells immune response. Taken together, these findings suggest a basic understanding of the sequence of immune activity following pIL-12 GET and also illuminates that adjuvant immunotherapy can have a positive influence on the host immune response to cancer. View Full-Text
Keywords: immunotherapy; gene therapy; melanoma; IL-12; electrotransfer immunotherapy; gene therapy; melanoma; IL-12; electrotransfer
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Shi, G.; Edelblute, C.; Arpag, S.; Lundberg, C.; Heller, R. IL-12 Gene Electrotransfer Triggers a Change in Immune Response within Mouse Tumors. Cancers 2018, 10, 498.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top